Structure-Guided Design of Hybrid Pyrazole-Based Cholinesterase Inhibitors: Elucidating the Role of N-Benzyl and O-Benzyl Substituents through Biological and Docking Studies
Pharmata · 13.11.2026 · 6 (3) · 129-140
DOI: 10.62425/pharmata.1953041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmata, online erschienen am 13.11.2026. Verfasst von Burak Kuzu und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objective
This study aimed to design, synthesize, and evaluate novel hybrid pyrazole-based cholinesterase inhibitors incorporating N-benzyl and O-benzyl fragments, combining distinct pharmacophoric features to enhance inhibitory potency and binding efficiency against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE).
Methods
A series of hybrid compounds was synthesized via a multi-step synthetic route involving semicarbazone formation, cyclization to pyrazole derivatives, N-benzylation, reduction, and final benzylation. Structural characterization was performed using 1H-NMR, 13C-NMR, and HRMS analyses. The inhibitory activities of the synthesized compounds against AChE and BChE were determined using the Ellman method, and IC50 values were calculated. Structure-activity relationship (SAR) analysis was conducted to evaluate the impact of structural variations. Molecular docking studies were performed using AutoDock 4.2 to investigate ligand-enzyme interactions and binding modes.
Results
The synthesized compounds exhibited varying degrees of cholinesterase inhibition, with several derivatives demonstrating notable AChE and BChE inhibitory activity. SAR analysis revealed that the presence of both N-benzyl and O-benzyl substituents, along with diverse aromatic moieties, significantly influenced inhibitory potency. Molecular docking studies supported the experimental findings, indicating favorable binding interactions within the active site of AChE and BChE, including π-π stacking and hydrophobic interactions.
Conclusion
These findings suggest that hybrid pyrazole-based scaffolds represent promising candidates for the development of novel cholinesterase inhibitors. The proposed hybrid design strategy provides a valuable framework for the rational development of more potent and selective anti-Alzheimer agents.
Zitieren
APA
Kuzu, B., Karcı, B. N., & Dönmez, F. (2026). Structure-Guided Design of Hybrid Pyrazole-Based Cholinesterase Inhibitors: Elucidating the Role of N-Benzyl and O-Benzyl Substituents through Biological and Docking Studies. Pharmata, 6(3), 129-140. https://doi.org/10.62425/pharmata.1953041
Vancouver
Kuzu B, Karcı BN, Dönmez F. Structure-Guided Design of Hybrid Pyrazole-Based Cholinesterase Inhibitors: Elucidating the Role of N-Benzyl and O-Benzyl Substituents through Biological and Docking Studies. Pharmata. 2026;6(3):129-140. doi:10.62425/pharmata.1953041
BibTeX
@article{Kuzu2026,
author = {Kuzu, Burak and Karcı, Beyza Nur and Dönmez, Fatih},
title = {Structure-Guided Design of Hybrid Pyrazole-Based Cholinesterase Inhibitors: Elucidating the Role of N-Benzyl and O-Benzyl Substituents through Biological and Docking Studies},
journal = {Pharmata},
year = {2026},
volume = {6},
number = {3},
pages = {129--140},
doi = {10.62425/pharmata.1953041}
}
EUVIMED